Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
About
Careers
Partners
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
About
Careers
Partners
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
Hepatology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
Tongue Hyperpigmentation With Peginterferon α-2b Therapy in Hepatitis B
4
Mins
May 2024
Peginterferon α-2b (Peg IFNα-2b), which inhibits viral replication in infected cells, suppresses cell proliferation, induces apoptosis, and…
Read more
9
Mins
28th May 2019
Overlap Syndrome with Autoimmune Hepatitis and Primary Sclerosing Cholangitis
The autoimmune liver diseases (AILD) have been categorised classically as either autoimmune hepatitis (AIH), primary sclerosing cholangitis (PSC)…
13
Mins
28th May 2019
Liver Fibrosis: A Clinical Update
Liver fibrosis is the common sequelae of chronic insult to the liver from any aetiology. The most common causes are alcohol-related, fatty liver disease…
9
Mins
28th September 2018
Covered Transjugular Intrahepatic Portosystemic Shunt in the Treatment of Portal Hypertension: Looking for the Right Patient and the Right Time
Transjugular intrahepatic portosystemic shunt. Portal hypertension is the main complication of cirrhosis and occurs due to increased pressure within the…
9
Mins
4th September 2018
Alcohol or Not: A Review Comparing Initial Mechanisms, Contributing Factors, and Liver Transplantation Outcomes Between Alcoholic and Nonalcoholic Steatohepatitis
Chronic liver diseases take many forms; alcohol-related liver disease (ALD) and nonalcoholic fatty liver disease (NAFLD) are two common illnesses that…
14
Mins
27th July 2018
Primary Biliary Cholangitis in Motion Meeting
The purpose of the meeting was to work towards unified best practice in the treatment of primary biliary cholangitis (PBC). This centred on a theme of…
12
Mins
7th June 2018
Modern Methods for Studying Portal Hypertension-Associated Angiogenesis in Experimental Research
Portal hypertension (PH) is associated with the majority of severe complications occurring in liver cirrhosis, and an increase in hepatic vascular…
11
Mins
7th June 2018
Practical Diagnosis and Staging of Nonalcoholic Fatty Liver Disease: A Narrative Review
As the rates of obesity increase worldwide, the prevalence of nonalcoholic fatty liver disease (NAFLD) has risen and it is now the most common cause of…
7
Mins
7th June 2018
The Adverse Impact of Sarcopenia and Visceral Fat Deposition on the Course of Hepatocellular Carcinoma and the Role of Nutritional Interventions
There is mounting evidence to support the impact of sarcopenia on the prognosis of a wide range of clinical conditions. This review examines the…
Loading posts...
« Previous
1
…
6
7
8
9
10
…
17
Next »